文献速递小儿神经外科与脑积水脊柱脊髓外科

脊髓脊膜膨出治疗的文献计量分析:国家疾病负担与发表量的对比

Bibliometric Analysis of Myelomeningocele Management: National Disease Burden versus Publication Volume.
PubMed 文献 · World Neurosurg · 2024-12-07

该文献计量分析系统检索脊髓脊膜膨出(MMC)神经外科治疗的文献,比较各国研究产出与其神经管缺陷(NTD)出生疾病负担。共纳入1843篇文献、代表107446例患者和2650次作者署名;高收入国家占2019年全球NTD出生的3%,却占作者署名的74%和所代表患者的83%,而低收入国家承担32%的NTD出生,仅贡献1.3%的作者署名和1.6%的患者。作者认为神经外科医生等需应对疾病负担与发表量之间的不匹配。

要点

  • 高收入国家占作者署名74%、所代表患者83%,而2019年全球NTD出生仅占3%。
  • 中低收入国家承担55%的NTD出生,仅占作者署名8.6%和患者7%。
  • 低收入国家承担32%的NTD出生,仅贡献作者署名1.3%和患者1.6%。

核心结论

  • 全球脊髓脊膜膨出神经外科治疗文献主要来自高收入国家。
  • 低收入和中低收入国家虽有大多数受累人群,但其脊髓脊膜膨出患者经验发表很少。
  • 作者认为神经外科医生和其他卫生专业人员必须应对疾病负担与发表量之间的这种不匹配,以指导全球脊髓脊膜膨出治疗的实践、政策和倡导。

研究设计与样本

  • 对脊髓脊膜膨出神经外科治疗方面进行系统文献检索。
  • 从9692条题录中纳入1843篇文献,代表107446例患者和2650次作者署名。
  • 按世界银行收入组分类和叶酸强化状态分层,比较作者与患者国家归属与疾病负担。

主要发现

  • 高收入国家占2019年全球神经管缺陷出生的3%、作者署名的74%、所代表患者的83%。
  • 中高收入国家占神经管缺陷出生的9%、作者署名的16%、所发表患者的9%。
  • 中低收入国家占神经管缺陷出生的55%,但仅占作者署名的8.6%和患者的7%。
  • 低收入国家承担神经管缺陷出生的32%,贡献作者署名的1.3%和患者的1.6%。
  • 实施强制性叶酸强化的国家占患者的75%和作者署名的54%。

关键数值与推荐

  • 出生后修复、脑积水和术后并发症是研究最频繁的主题。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Myelomeningocele (MMC) disproportionately affects low-resource areas and regions without mandatory folic acid fortification. No specific literature exists on the distribution of research output regarding neurosurgical management of myelomeningocele worldwide in relation to regional disease burden. We aimed to examine the country of origin and patient population of published papers on MMC and topics related to neurosurgical management of MMC, to determine whether these were proportionate to disease burden. METHODS: A systematic literature search was conducted on neurosurgical aspects of MMC care. The geographic distribution of neurosurgical MMC research output was examined against the national burden of disease. Bibliometric analysis quantified author and patient country affiliations stratified by World Bank income group classification and folic acid fortification status, juxtaposed with disease burden. RESULTS: From 9692 titles, 1843 were included, representing 107,446 patients and 2650 authorship instances. High-income countries (HICs) constituted 3% of 2019's global neural tube defect (NTD) births, 74% of authorships, and 83% of patients represented. Upper-middle-income countries (UMICs) represented 9% of NTD births, 16% of authorships, and 9% of published patients. Lower-middle-income countries (LMICs) represented 55% of NTD births but only 8.6% of authorships and 7% of patients. Low-income countries (LICs) shouldered 32% of NTD births and contributed 1.3% of authorships and 1.6% of patients. Countries with mandatory folic acid fortification represented 75% of patients and 54% of authorships. Postnatal repair, hydrocephalus, and postoperative complications were the most frequently studied topics. CONCLUSIONS: The global literature concerning neurosurgical management of myelomeningocele originates predominantly from HICs. Published experiences of myelomeningocele patients from LICs/LMICs are scarce, even though they constitute the majority of the affected population. Neurosurgeons and other health professionals must address this mismatch between disease burden and publication volume in order to inform practice, policy, and advocacy for MMC care worldwide.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Shao B, Harlyjoy A, Kozel OA, et al. Bibliometric Analysis of Myelomeningocele Management: National Disease Burden versus Publication Volume. World Neurosurg. 2024. PMID: 39571894. doi:10.1016/j.wneu.2024.11.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。